期刊文献+

血管活性肠肽对暂时性脑缺血大鼠梗死体积的影响 被引量:2

Effects of vasoactive intestinal peptide on the infarct volume in rat transient focal cerebral Ischemia
下载PDF
导出
摘要 目的通过活体实验研究血管活性肠肽(VIP)对脑缺血损伤的神经保护作用。方法大鼠侧脑室内注射VIP后,采用大脑中动脉线栓(MCAO)法诱导建立暂时性局部脑缺血模型。通过神经学的评价对MCAO大鼠进行判定和筛选;TTC染色测定大鼠脑梗死体积;双抗夹心ELISA检测血清S100β的含量。结果MCAO后2 h大鼠呈现不同程度的神经功能损伤症状。评定为1-2级的仅有2例出现明显脑梗死区,3级的为全部。VIP注射后大鼠脑梗死体积明显缩小,较对照组减少约25%(P<0.05);血清S100β浓度也明显降低(P<0.05)。结论以神经学评分3级作为MCAO模型成功的判定标准是较为可靠的。VIP脑内注射可明显减小脑缺血后梗死体积,具有神经保护作用。VIP可以降低S100β的含量,这可能涉及到VIP的另一神经保护机制。 Objective To explore the neuroprotective effects of vasoactive intestinal peptide (VIP) on ischemic brain injury in vivo. Methods In the present study, VIP was given via intracerebroventriclar injection, and then focal cerebral ischemia was induced in SD rats by intraluminal occlusion of middle cerebral artery (MACO) for 120 min. The evaluation and screening of rats with successful occlusion of MCA were performed by neurological testing. The infarct volume was investigated with 2, 3, 5-triphenyltetrazolium chloride (TTC) stain. S100fl concentration in serum was detected by double-antibodies-sandwich-ELISA method. Results The different grades of neurological severity appeared obviously in all the rats at 2 hours after MCAO. Only two rats that scored grade 1 or 2 had identifiable areas of infarction, whereas the areas of infarction in all the rats that were scored grade 3 were identified. Compared to the control groups at 1 day, injection of VIP significantly reduced the relative infarct volume by approximately 25% (P〈0. 05), and then remarkably decreased S100 β serum concentration (P〈0.05). Conclusion The grade 3 of neurological score as a standard to evaluate successful occlusion of MCA is satisfactory and reliable. VIP injection can reduce the infarct volume in a rat model of focal cerebral ischemia. The present study provides further evidence for the neuroprotective effects of VIP in vivo. VIP may decrease S100 β serum concentration, which may involve one of the mechanisms of the neuroprotective effect of VIP.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第5期494-497,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金资助项目(No.30570976)
关键词 血管活性肠肽 脑缺血 梗死体积 S100Β vasoactive intestinal peptide cerebral ischemia infarct volume S100 β
  • 相关文献

参考文献10

  • 1Dejda A,Sokolowska P,Nowak JZ.Neuroprotective potential of three neuro-peptides PACAP,VIP and PHI[J].Pharmacol Rep,2005,57(3):307-320.
  • 2Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without cranioctomy in rats[J].Stroke,1989,20(1):84-91.
  • 3Bederson JB,Pitts LH,Tsuji M,et al.Rat middle cerebral artery occlusion:evaluation of the model and development of a neurologic examination[J].Stroke,1986,17(3):472-476.
  • 4Brown DR.Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity[J].Mol Cell Neurosci,2000,15(5):465-475.
  • 5Onoue S,Endo K,Yajima T,et al.Pituitary adenylate cyclaseactivating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity[J].Regul Pept,2002,107(1-3):43-47.
  • 6Buttner T,Weyers S,Postert T,et al.S-100 protein:serum marke of focal brain damage after ischemic territorial MCA infarction[J].Stroke,1997,28(10):1961-1965.
  • 7Elting JW,de Jager AE,Teelken AW,et al.Comparison of serum S-100 protein levels following stroke and traumatic brain injury[J].J Neurol Sci,2000,181(1-2):104 110.
  • 8Yasuda Y,Tateishi N,Shimoda T,et al.Relationship between S100 beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia[J].Brain Res,2004,1021(1):20-31.
  • 9杨杰,刘勇,钱亦华,胡海涛,邱芬,郭世萍.β-淀粉样蛋白诱导大鼠海马S100β表达的作用及机制[J].西安交通大学学报(医学版),2004,25(4):322-325. 被引量:7
  • 10Donato R.S100:a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles[J].Int J Biochem Cell Biol,2001,33(7):637-668.

二级参考文献10

  • 1Mrak RE, Sheng JG, Griffin WST. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease [J]. J Neuropathol Exp Neurol, 1996, 55(3):273-279.
  • 2Sheng JG, Ito K, Skinner RD, et al. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis [J]. Neurobiol Aging, 1996,17(5):761-766 .
  • 3Griffin WS, Sheng JG, Royston MC. Glial-neuronal interaction in Alzheimer's disease: the potential role of a ''cytokine cycle'' in disease progression [J]. Brain Pathol, 1998, 8(1): 65 -72.
  • 4Pena LA, Brecher CW, Marshak DR. Beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures [J]. Brain Res Mol Brain Res,1995,34(1):118-126.
  • 5McGeer PL, McGeer EG. Mechanisms of cell death in Alzheimer disease: Immunopathology [J]. J Neural Transm Suppl, 1998,54:159-166.
  • 6Bluthé RM, Beaudu C, Kelley KW, et al. Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats [J]. Brain Res, 1995, 677(1):171-176.
  • 7Mrak RE, Griffinbc WS. The role of activated astrocytes and of the neurotrophic cytokine S100β in the pathogenesis of Alzheimer's disease [J]. Neurobiol Aging, 2001, 22(6):915-922.
  • 8Qian YH, Liu Y, Hu HT, et al. The effects of the total saponin of Dipsacus asperoides on the damage of cultured neurons induced by β-amyloid protein 25-35 [J]. Anat Sci Int, 2002, 77(3):196-200.
  • 9杨杰,钱亦华,胡海涛,张樟进,王唯析,胡晓丹.维生素E对Alzheimer病模型大鼠的影响[J].中国老年学杂志,1998,18(2):95-97. 被引量:19
  • 10杨杰,钱亦华,胡海涛,陈新林,陈国敏.β-淀粉样蛋白对大鼠海马S100β表达及学习记忆的影响[J].中国老年学杂志,2004,24(2):149-150. 被引量:4

共引文献6

同被引文献52

  • 1Wei Huang,Shu-Man Jiang,Lin Jia,Le-Qing You,Yao-Xing Huang,Yan-Mei Gong,Gui-Qin Wang.Effect of amitriptyline on gastrointestinal function and brain-gut peptides: A double-blind trial[J].World Journal of Gastroenterology,2013,19(26):4214-4220. 被引量:35
  • 2肖丹,康健,胡雪君,王秋月,侯显明,于润江.阻塞型睡眠呼吸暂停低通气综合征患者血管活性肠肽与睡眠质量的关系[J].首都医科大学学报,2004,25(4):493-496. 被引量:5
  • 3杜静,张连峰,秦川.胆囊收缩素作用的研究进展[J].中国比较医学杂志,2007,17(4):233-236. 被引量:29
  • 4Martin B, Lopez de Maturana R, Brenneman R, Walent T, Mattson MP, Maudsley S. Class II G Protein - coupled -ceptors and their lig- ands in neuronal function and protection. Neuromolecular Med. 2005,7 (1 - 2) :3 -36.
  • 5Dickson L, Finlayson K. VPAC and PAC receptors:from ligands to function. Phannacol. Ther. 2009,121 ( 3 ) :294 - 316.
  • 6Martin B, Shin YK, White CM, Ji S, Kim W, et al. Vasoactive intestinal peptide - null mice demonstrate enhanced sweet taste preference, dysg- lycemia and reduced taste bud leptin receptor expression. Diabetes. 2010,59(5) :1143 -52.
  • 7Waschek JA. VIP and PACAP: neuropeptide modulators of CNS inflam- mation,injury, and repair. Br J Pharmacol. 2013,169 ( 3 ) :512 - 523.
  • 8Onoue s, Missaka s, Yamada s. Structure -activity relationship of vaso- active intestinal petide(VIP) :potent agonists and po -tential clinical applications. Naunyn - Schmiedeberg' s Arch Pharmacol, 2008,377 (4 -6) :579 -590.
  • 9Whitworth E J, Kostio, Renshaw D, et al. Adrenal neuropeptides : Reg- ulation and interaction with ACTH and other adrenal regula - tors. Microse Res Tech,2003,61:259.
  • 10Ribatti D, Conconi MT, Nussdorfer GG. Nonclassic endogenous novel [ corrected ] regulators of angiogenesis. Pharmacol Rev, 2007,59 ( 2 ) : 185 - 205.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部